Whereas genetic deletion and inhibition of NF-κB led to an anti-tumor effect in these models, defective NF-κB activity was also reported in tumor associated macrophages from a late stage murine sarcoma model, and restoring NF-κB activity was associated with tumor regression in a mouse mammary carcinoma model69–71. Here, NFKB1 is linked to breast carcinoma.